Thursday, July 9, 2026

pharma · NRXP

NRX Pharmaceuticals

NRX Pharmaceuticals patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

WILMINGTON, DE, USA HQ
Public company Type
NRXP · NYSE Ticker
Company details
Status
Public
HQ
WILMINGTON, DE, USA
Programs
0
Drugs
0
Patents
1
Intelligence · Patents

NRX Pharmaceuticals patents

1 pharmaceutical patents indexed for NRX Pharmaceuticals. 0 expire within 24 months.

NRX Pharmaceuticals has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 7662820

    Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does NRX Pharmaceuticals have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do NRX Pharmaceuticals patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.